Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Jad M Abdelsattar, M.D, FACS

Breast Surgical Onc · University of Oxford

View

Dr. Lauren Kopicky

Breast Surgical Onc · Cleveland Clinic

View

Dr. Jennifer Plichta

Breast Surgical Onc · Duke University

View

Dr. Sarah Blair

Breast Surgical Onc · UCSD

View

Dr. Karen Goodwin

Breast Surgical Onc · UCSF

View

Dr. Christin Collins

Breast Surgical Onc · MetroHealth

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Todd Rosengart

Cardiac Surgery · BCM

View

Dr. Larry Kaiser

Thoracic Surgery · UPenn

View

Dr. Neri Cohen

Thoracic Surgery · XVIVO

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Practice Patterns and Overall Survival for Octogenarians with Triple Negative Breast Cancer Treated at Accredited Cancer Centers in the USA.

    Jul 10, 2026DOI: 10.1245/s10434-026-20133-1Journal ArticleASO

    Written by: Alexandra L MathewsBetty FanCatherine PesceKatherine KopkashElizabeth PoliThomas SmithCecilia ChangCecylia MizeraKatharine Yao

    Find these authors on Roon

    KY
    Dr. Katharine Yao
    Breast Surgical Onc · Endeavor Health

    Summary

    BACKGROUND: The purpose of this study was to examine treatment patterns and overall survival (OS) for patients ≥ 80 years with triple negative breast cancer (TNBC).PATIENTS AND METHODS: The National Cancer Data Base was queried for patients ≥ 80 years old diagnosed with TNBC from 2012 to 2022. Patients with T1a or Tis tumors or distant metastatic disease were excluded. Charlson-Deyo comorbidity scores were used to assess comorbidity burden. Treatment patterns of chemotherapy, radiation therapy, and surgery were examined. OS was estimated using Kaplan-Meier curves and multivariable Cox proportional hazards models evaluated factors associated with OS.RESULTS: In total, 10,767 patients met inclusion criteria: 5876 (54.5%) were aged 80-84 years, 3296 (30.6%) were 85-89, and 1595 (14.8%) were ≥ 90. Most patients had a Charlson-Deyo score of 0 (69.53%), while 565 patients (5.25%) had scores ≥ 3. Surgery alone was performed in 6916 (64.23%) patients, while 2584 (24.0%) underwent surgery plus chemotherapy, 811 (7.5%) received no treatment, and 284 (2.63%) received chemotherapy alone. Regional lymph nodes were tumor positive in 3001 patients (27.87%). On multivariable analysis, surgery (HR 0.36; 95% CI 0.32-0.41, p < 0.0001) and surgery plus chemotherapy (HR 0.23; 95% CI 0.20-0.27, p < 0.0001) were associated with improved OS when compared with no treatment. At 2.5 years of follow-up, OS was 22.2% for patients who received no treatment, 69.5% for surgery, and 77.6% for surgery plus chemotherapy.CONCLUSIONS: Surgical management of TNBC in octogenarians is associated with improved OS, with the greatest survival seen in patients undergoing surgery and chemotherapy. These findings are not causal but demonstrate that some octogenarians derive survival benefit from surgery and systemic treatment.
    KYDr. Katharine Yao

    Dr. Katharine Yao

    Surgery · Breast Surgical Oncology
    Endeavor Health
    katharine